Neumann AU - Search Results

1

A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.

Balan V, Nelson DR, Sulkowski MS, Everson GT, Lambiase LR, Wiesner RH, Dickson RC, Post AB, Redfield RR, Davis GL, Neumann AU, Osborn BL, Freimuth WW, Subramanian GM. Balan V, et al. Among authors: neumann au. Antivir Ther. 2006;11(1):35-45. Antivir Ther. 2006. PMID: 16518958 Clinical Trial.

2

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients.

Bain VG, Kaita KD, Yoshida EM, Swain MG, Heathcote EJ, Neumann AU, Fiscella M, Yu R, Osborn BL, Cronin PW, Freimuth WW, McHutchison JG, Subramanian GM. Bain VG, et al. Among authors: neumann au. J Hepatol. 2006 Apr;44(4):671-8. doi: 10.1016/j.jhep.2005.12.011. Epub 2006 Jan 30. J Hepatol. 2006. PMID: 16487617 Clinical Trial.

3

Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis C.

Neumann AU, Bain VG, Yoshida EM, Patel K, Pulkstenis E, Subramanian GM. Neumann AU, et al. Liver Int. 2009 Oct;29(9):1350-5. doi: 10.1111/j.1478-3231.2009.02005.x. Epub 2009 Mar 11. Liver Int. 2009. PMID: 19291180

4

Hepatitis C virus kinetics.

Herrmann E, Neumann AU, Schmidt JM, Zeuzem S. Herrmann E, et al. Among authors: neumann au. Antivir Ther. 2000 Jun;5(2):85-90. Antivir Ther. 2000. PMID: 10971860 Review.

5

Rapid decrease of wild-type hepatitis C virus on telaprevir treatment.

Adiwijaya BS, Hare B, Caron PR, Randle JC, Neumann AU, Reesink HW, Zeuzem S, Herrmann E. Adiwijaya BS, et al. Among authors: neumann au. Antivir Ther. 2009;14(4):591-5. Antivir Ther. 2009. PMID: 19578245 Clinical Trial.

6

First phase hepatitis c viral kinetics in previous nonresponders patients.

Cotler SJ, Layden JE, Neumann AU, Jensen DM. Cotler SJ, et al. Among authors: neumann au. J Viral Hepat. 2003 Jan;10(1):43-9. doi: 10.1046/j.1365-2893.2003.00401.x. J Viral Hepat. 2003. PMID: 12558911

7

Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C.

Layden TJ, Layden JE, Reddy KR, Levy-Drummer RS, Poulakos J, Neumann AU. Layden TJ, et al. Among authors: neumann au. J Viral Hepat. 2002 Sep;9(5):334-9. doi: 10.1046/j.1365-2893.2002.00376.x. J Viral Hepat. 2002. PMID: 12225327

8

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.

Wolf DG, Shimoni A, Resnick IB, Stamminger T, Neumann AU, Chou S, Efferth T, Caplan O, Rose J, Nagler A, Marschall M. Wolf DG, et al. Among authors: neumann au. Antiviral Res. 2011 Jun;90(3):183-6. doi: 10.1016/j.antiviral.2011.03.184. Epub 2011 Apr 3. Antiviral Res. 2011. PMID: 21443904 Free PMC article.

9

Antiviral action of ribavirin in chronic hepatitis C.

Pawlotsky JM, Dahari H, Neumann AU, Hezode C, Germanidis G, Lonjon I, Castera L, Dhumeaux D. Pawlotsky JM, et al. Among authors: neumann au. Gastroenterology. 2004 Mar;126(3):703-14. doi: 10.1053/j.gastro.2003.12.002. Gastroenterology. 2004. PMID: 14988824

10

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa.

Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden TJ. Lam NP, et al. Among authors: neumann au. Hepatology. 1997 Jul;26(1):226-31. doi: 10.1002/hep.510260130. Hepatology. 1997. PMID: 9214474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page